These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8543166)

  • 21. A novel ribozyme target site located in the HIV-1 nef open reading frame.
    Larsson S; Hotchkiss G; Su J; Kebede T; Andäng M; Nyholm T; Johansson B; Sönnerborg A; Vahlne A; Britton S; Ahrlund-Richter L
    Virology; 1996 May; 219(1):161-9. PubMed ID: 8623525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
    Liang C; Li X; Quan Y; Laughrea M; Kleiman L; Hiscott J; Wainberg MA
    J Mol Biol; 1997 Sep; 272(2):167-77. PubMed ID: 9299345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.
    Jurriaans S; de Ronde A; Dekker J; Cornelissen M; Goudsmit J
    J Med Virol; 1995 Jan; 45(1):91-8. PubMed ID: 7714497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
    Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H
    Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of chimeric neo-Rev response element sequences interferes with Rev-dependent HIV-1 Gag expression.
    Zimmermann K; Weber S; Dobrovnik M; Hauber J; Böhnlein E
    Hum Gene Ther; 1992 Apr; 3(2):155-61. PubMed ID: 1391035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
    Chadwick DR; Lever AM
    Gene Ther; 2000 Aug; 7(16):1362-8. PubMed ID: 10981662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of HIV-1 expression by HIV-2.
    Rappaport J; Arya SK; Richardson MW; Baier-Bitterlich G; Klotman PE
    J Mol Med (Berl); 1995 Dec; 73(12):583-9. PubMed ID: 8825754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.
    Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro.
    Veal GJ; Agrawal S; Byrn RA
    Nucleic Acids Res; 1998 Dec; 26(24):5670-5. PubMed ID: 9837998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.
    Simon G; Moog C; Obert G
    Chem Biol Interact; 1994 Jun; 91(2-3):111-21. PubMed ID: 7514959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.
    Branda RF; Moore AL; Mathews L; McCormack JJ; Zon G
    Biochem Pharmacol; 1993 May; 45(10):2037-43. PubMed ID: 8512586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
    Lund OS; Nielsen JO; Hansen JE
    Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans.
    Gnabre JN; Brady JN; Clanton DJ; Ito Y; Dittmer J; Bates RB; Huang RC
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11239-43. PubMed ID: 7479972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
    Agrawal S; Tang JY
    Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378
    [No Abstract]   [Full Text] [Related]  

  • 38. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.
    Yamaguchi K; Papp B; Zhang D; Ali AN; Agrawal S; Byrn RA
    AIDS Res Hum Retroviruses; 1997 May; 13(7):545-54. PubMed ID: 9135872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
    Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.